Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events (TRACE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by Xijing Hospital.
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
Xijing Hospital Identifier:
First received: July 19, 2013
Last updated: August 13, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):